Celldex Therapeutics buy Citigroup Inc.
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€41.27
Performance (%)
4.35%
Price
21.08.25
€17.80
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ shows slight gains of 4.35%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Celldex Therapeutics | 4.35% |
iShares Core DAX® | -0.099% |
iShares Nasdaq 100 | -1.085% |
iShares Nikkei 225® | -0.835% |
iShares S&P 500 | 0.099% |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Citigroup Inc. from $56.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€28.20
07.10.24
07.10.24
€63.74
07.10.25
07.10.25
-31.91%
21.08.25
21.08.25